1. Home
  2. PRAX vs TTC Comparison

PRAX vs TTC Comparison

Compare PRAX & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$288.69

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Logo Toro Company (The)

TTC

Toro Company (The)

N/A

Current Price

$97.57

Market Cap

8.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAX
TTC
Founded
2015
1914
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Tools/Hardware
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.8B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PRAX
TTC
Price
$288.69
$97.57
Analyst Decision
Strong Buy
Buy
Analyst Count
19
6
Target Price
★ $638.68
$111.00
AVG Volume (30 Days)
357.8K
★ 753.8K
Earning Date
11-04-2026
09-03-2026
Dividend Yield
N/A
★ 1.62%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 2.99
Revenue
N/A
★ $2,618,650,000.00
Revenue This Year
N/A
$6.31
Revenue Next Year
$39,590.54
$4.19
P/E Ratio
★ N/A
$32.55
Revenue Growth
N/A
★ 4.53
52 Week Low
$50.31
$67.64
52 Week High
$392.70
$105.19

Technical Indicators

Market Signals
Indicator
PRAX
TTC
Relative Strength Index (RSI) 35.63 51.79
Support Level $282.35 $91.34
Resistance Level $354.17 $96.55
Average True Range (ATR) 14.63 1.87
MACD -1.65 0.37
Stochastic Oscillator 21.96 69.06

Price Performance

Historical Comparison
PRAX
TTC

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

Share on Social Networks: